Inhibitory effects of icotinib combined with antiangiogenic drugs in human non‐small cell lung cancer xenograft models are better than single target drugs

BACKGROUND: This study aimed to evaluate the inhibitory effects and potential mechanisms of icotinib combined with antiangiogenic drugs on lung adenocarcinoma in vivo. METHODS: A total of 72 mouse xenograft models established with human lung adenocarcinoma cells (HCC827) were randomly divided into s...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Peng, Zhang, Yan, Cui, Jiadong, Wang, Xiuxiu, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758432/
https://www.ncbi.nlm.nih.gov/pubmed/34855286
http://dx.doi.org/10.1111/1759-7714.14261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758432/
https://www.ncbi.nlm.nih.gov/pubmed/34855286
http://dx.doi.org/10.1111/1759-7714.14261

Ejemplares similares